NEW DELHI: Indian pharmaceutical giant Sun PharmaBSE -0.19 % has partnered with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine that would be safe, effective and...
St. Jude, Abbott Sell Products to Terumo for $1.12 Billion
Abbott Laboratories and St. Jude Medical Inc. will divest some of their cardiovascular products to Terumo Corp. for $1.12 billion in order to complete the $25 billion deal between the two medical device giants. The all...
Cipla signs deal to set up first biosimilars unit in South Africa
Johannesburg:Indian pharmaceutical major Cipla has signed a memorandum of agreement for South Africa’s first biosimilars manufacturing facility to be set up at a cost of nearly $91 million. The agreement with KwaZulu...
Dilip Shanghvi, M&A artist behind India’s best stock, now faces his greatest test
Mumbai: When Dilip Shanghvi wants something, he has a track record of getting it. One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceuticals Industries Ltd calling more than 100 times over three years...
Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 crore
Piramal Enterprises has agreed to acquire five injectable anesthesia and pain management products of Janssen Pharmaceutica for about $175 million or Rs 1,164 crore. Mumbai-headquartered Piramal Enterprises will pay $155...
ChrysCapital set to exit Eris Lifesciences in $200 million IPO
Mumbai: Eris Lifesciences Pvt. Ltd has hired three investment banks to manage its initial share sale, offering private equity investor ChrysCapital an opportunity to sell its entire stake in the drug maker, three people...
Intas buys Teva’s UK & Ireland assets for $764 million to break into global top 20 generic players club
MUMBAI: Closely held Ahmedabad drugmaker Intas Pharmaceuticals has trumped larger domestic peer Aurobindo PharmaBSE 2.13 % and Cinven, a London-headquartered private equity firm to acquire assets of Teva Pharmaceuticals...
Mitsubishi backs Aurobindo, Intas for Teva asset bid
Japanese giant Mitsubishi UFJ Financial Group has emerged as the most prominent banker in Teva Pharmaceuticals’ asset sale in the UK and Ireland. It is backing Indian firms Aurobindo Pharma and Intas Pharmaceuticals...
Netmeds in talks to buy medicine delivery startup Pluss
NEW DELHI: Chennai-based online pharmacy Netmeds is in late-stage discussions to acquire on-demand medicine and healthcare products delivery service Pluss in an all-stock deal, with the merged entity looking to...
Pfizer concludes Rs 110 crore deal with Piramal Enterprises
Drug maker Pfizer on Monday said it has completed the process of transferring four products to Mumbai-based Piramal Enterprises after getting necessary regulatory approvals. “Post completion of requisite...
Pharmacy Chain 36.6 plans to complete merger with A5 in December
** Pharmacy Chain 36.6 plans to complete merger with A5 in early December and the joint network aims to open up to 1,000 pharmacies in the regions organically, the pharmacy representatives said at a press conference on...
Allergan buys two liver drug makers in a day
Boston: Allergan Plc is on a shopping spree. In less than 12 hours on Tuesday, the drug maker announced a pair of acquisitions of firms developing treatments for a liver disease known as NASH, giving the firm a ready...
